Follow the Money…....and the dates. While I was surprised (disappointed) at the extent of the offerings as presented in the NR today, there are caveats.
* you need money to make money and there is little to none of it on hand at the moment for THRM
* according to the CMS, the codes for Venowave don't take effect until next week
* no codes, no sales, no revenue, no cash
* if Venowave sales do accelerate in the next few weeks cash will be required to ramp up production ...if that hadn't started already.
* while an R/S may eventually be necessary it will only happen if Venowave proves initially successful and/or there is/are significant updates on THRMs other interests.
Venowave is a fantastic device that "should" make significant inroads into the $$$ available connected to blood clot prevention and circulation enhancement. There is really nothing like it on the market and none that have had their product validated with the issuance of reimbursement codes.
GLTE ...holding patiently, if not tentatively!!!